Healthcare Global Enterprises Divests Entire Stake in BACC Health Care to Inviga Healthcare Fund I
Healthcare Global Enterprises Limited announced the execution of a Share Purchase Agreement (SPA) concerning the divestment of its entire equity shareholding in BACC Health Care Private Limited. The transaction involved the sale of the stake in BACC to Inviga Healthcare Fund I.The Company confirmed that the SPA was executed on May 19, 2026. The total consideration for the sale was determined to be INR 37,64,44,788 (Indian Rupees Thirty Seven Crores Sixty Four Lakhs Forty Four Thousand Seven Hundred and Eighty Eight Only).
According to the company statement, BACC Health Care Private Limited is engaged in the business of fertility and reproductive healthcare services. HCG noted that BACC is not a material subsidiary to the company and that this activity falls outside the core business operations of Healthcare Global Enterprises Limited. The transaction was approved by the Board and Audit Committee.
Financial Details and Transaction Structure
The sale transaction is structured in multiple tranches. The company is expected to receive a total consideration of INR 37,64,44,788, subject to agreed deductions or adjustments under the SPA.The expected payment schedule is detailed below:
| Consideration Component | Amount (INR) | Notes |
|---|---|---|
| Aggregate consideration on date of closing | 28,23,33,591 | Includes funds received on the closing date. |
| Aggregate deferred consideration | 9,41,11,197 | Expected within 18 months of the SPA signing. |
| Total Consideration | 37,64,44,788 | (Indian Rupees Thirty Seven Crores Sixty Four Lakhs Forty Four Thousand Seven Hundred and Eighty Eight Only) |
The transaction is classified as a related party transaction and is being undertaken on an arm's length basis, based on a valuation report from an independent third-party valuer.
Operational Timeline and Participants
The completion of the proposed transaction is anticipated to take place within 4 to 5 weeks from the date of the announcement, pending the terms of the SPA.The buyer in this divestment is Inviga Healthcare Fund I and its nominee. The funding structure involves Dr. B.S. Ajaikumar, who serves as the Promoter and Non-Executive Chairman of HCG and is the Sponsor of Inviga Healthcare Fund I. He is also the Promoter of Inviga Investment Advisors Private Limited, which acts as the Investment Manager for the Fund.
In terms of operational metrics for the financial year 2025-26, BACC generated a Revenue From Operations of 60.45 Crores and recorded a Net worth of 17.53. These figures represent 4.45% and 1.09% of HCG’s standalone revenue and net worth, respectively.
HCG Stock Price Movement
On Tuesday, Healthcare Global Enterprises Limited shares edged higher to close at ₹646.85, gaining 2.73% above their previous closing levels. The stock experienced a trading range between ₹632 and ₹653.7, finalizing the session on a notable volume of 132,428 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.